TY - JOUR
T1 - Evaluating a multimodal, clinical and work-directed intervention (RTW-PIA) to support sustainable return to work among employees with mental disorders
T2 - study protocol of a multicentre, randomised controlled trial
AU - Starke, Fiona
AU - Sikora, Alexandra
AU - Stegmann, Ralf
AU - Knebel, Leonie
AU - Buntrock, Claudia
AU - de Rijk, Angelique
AU - Houkes, Inge
AU - Szycik, Gregor R.
AU - Unger, Hans-Peter
AU - Schumacher, Jan Ole
AU - Stark, Heiko
AU - Hauth, Iris
AU - Holzapfel, Christian
AU - Borgolte, Anna
AU - Schneller, Carlotta
AU - Unterschemmann, Sarah-Louise
AU - Paetow, Wiebke
AU - Jung, Anna Lena
AU - Berking, Matthias
AU - Zimmermann, Johannes
AU - Wegewitz, Uta
PY - 2023/5/30
Y1 - 2023/5/30
N2 - Background Mental disorders (MDs) are one of the leading causes for workforce sickness absence and disability worldwide. The burden, costs and challenges are enormous for the individuals concerned, employers and society at large. Although most MDs are characterised by a high risk of relapse after treatment or by chronic courses, interventions that link medical-psychotherapeutic approaches with work-directed components to facilitate a sustainable return to work (RTW) are rare. This protocol describes the design of a study to evaluate the (cost-)effectiveness and implementation process of a multimodal, clinical and work-directed intervention, called RTW-PIA, aimed at employ-ees with MDs to achieve sustainable RTW in Germany.Methods The study consists of an effectiveness, a health-economic and a process evaluation, designed as a two-armed, multicentre, randomised controlled trial, conducted in German psychiatric outpatient clinics. Sick-listed employees with MDs will receive either the 18-month RTW-PIA treatment in conjunction with care as usual, or care as usual only. RTW-PIA consists of a face-to-face individual RTW support, RTW aftercare group meetings, and web-based aftercare. Assessments will be conducted at baseline and 6, 12, 18 and 24 months after completion of baseline survey. The primary outcome is the employees' achievement of sustainable RTW, defined as reporting less than six weeks of working days missed out due to sickness absence within 12 months after first RTW. Secondary outcomes include health-related quality of life, mental functioning, RTW self-efficacy, overall job satisfaction, severity of mental illness and work ability. The health-economic evaluation will be conducted from a societal and public health care perspective, as well as from the employer's perspective in a cost-benefit analysis. The design will be supplemented by a qualitative effect evaluation using pre-and post-interviews, and a multimethod process evaluation examining various predefined key process indicators from different stakeholder perspectives. Discussion By applying a comprehensive, multimethodological evaluation design, this study captures various facets of RTW-PIA. In case of promising results for sustainable RTW, RTW-PIA may be integrated into standard care within German psychiatric outpatient clinics.
AB - Background Mental disorders (MDs) are one of the leading causes for workforce sickness absence and disability worldwide. The burden, costs and challenges are enormous for the individuals concerned, employers and society at large. Although most MDs are characterised by a high risk of relapse after treatment or by chronic courses, interventions that link medical-psychotherapeutic approaches with work-directed components to facilitate a sustainable return to work (RTW) are rare. This protocol describes the design of a study to evaluate the (cost-)effectiveness and implementation process of a multimodal, clinical and work-directed intervention, called RTW-PIA, aimed at employ-ees with MDs to achieve sustainable RTW in Germany.Methods The study consists of an effectiveness, a health-economic and a process evaluation, designed as a two-armed, multicentre, randomised controlled trial, conducted in German psychiatric outpatient clinics. Sick-listed employees with MDs will receive either the 18-month RTW-PIA treatment in conjunction with care as usual, or care as usual only. RTW-PIA consists of a face-to-face individual RTW support, RTW aftercare group meetings, and web-based aftercare. Assessments will be conducted at baseline and 6, 12, 18 and 24 months after completion of baseline survey. The primary outcome is the employees' achievement of sustainable RTW, defined as reporting less than six weeks of working days missed out due to sickness absence within 12 months after first RTW. Secondary outcomes include health-related quality of life, mental functioning, RTW self-efficacy, overall job satisfaction, severity of mental illness and work ability. The health-economic evaluation will be conducted from a societal and public health care perspective, as well as from the employer's perspective in a cost-benefit analysis. The design will be supplemented by a qualitative effect evaluation using pre-and post-interviews, and a multimethod process evaluation examining various predefined key process indicators from different stakeholder perspectives. Discussion By applying a comprehensive, multimethodological evaluation design, this study captures various facets of RTW-PIA. In case of promising results for sustainable RTW, RTW-PIA may be integrated into standard care within German psychiatric outpatient clinics.
KW - Return to work
KW - Mental disorders
KW - Relapse prevention
KW - RCT
KW - Sickness absence
KW - Multimodal Intervention
KW - Sustainability
KW - SRTW
KW - Protocol
KW - RECURRENT SICKNESS ABSENCE
KW - PSYCHOTHERAPEUTIC CONSULTATION
KW - REHABILITATION AFTERCARE
KW - ECONOMIC-EVALUATION
KW - TO-WORK
KW - HEALTH
KW - COSTS
KW - METAANALYSIS
KW - DISABILITY
KW - DEPRESSION
U2 - 10.1186/s12888-023-04753-5
DO - 10.1186/s12888-023-04753-5
M3 - Article
SN - 1471-244X
VL - 23
JO - BMC Psychiatry
JF - BMC Psychiatry
IS - 1
M1 - 380
ER -